- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01742377
Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients (MCE)
i-Scan Endoscopy in the Detection of Minimal Change Esophagitis in Dyspeptic Patients With or Without Gastroesophageal Reflux Disease by Gerd Q Questionnaire and by 24 Hour pH Monitoring.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: The association of minimal change esophagitis (MCE) with gastroesophageal reflux (GERD) is controversy. High resolution endoscopy may improve the detection of minimal change lesion (MCL). i- Scan endoscopy (SE) provides high resolution images with modulation of images for a specific purpose.
Methods. All dyspeptic patients with or without GERD symptoms scheduled for endoscopy were recruited from February 2010 till July 2014. All completed the validated Thai version of GerdQ then underwent endoscopy. Forty normal volunteers were recruited for endoscopy and PHM test. The esophagus was examined by HD and SE with the TE-e mode sequentially. The captured images were independently evaluated for MCL (punctate erythema (PE), minute erosion (ME) and triangular lesion with elongated pit (EP) by three endoscopists. The agreement of > 2 endoscopists was accepted as a final result. All had PHM within 1 week after the endoscopy. GERD was diagnosed by LA grade A-D esophagitis and/or PHM with acid exposure time > the upper limit of volunteer and/or positive symptom index and/or positive Symptom Association Probability. MCE was diagnosed when PE, ME or EP or the combination of these were present.
The 40 normal volunteers were recruited for performing pH monitoring. The PHM data of 40 volunteers were analyzed to set the upper normal limit of total acid exposure time in our population. The mean + 2SD of total acid exposure time of volunteers was 1.9%.
Definition. GerdQ. The Thai version of GerdQ was translated from the English version. The contents of the GerdQ were tested by back translation from Thai to English by 5 personnel who are fluent in English and all showed the consistent contents. The reliability of the GerdQ was validated in 22 volunteers completing the questionnaire twice with 3 hours in between and showed no significant difference of the mean score (5.14+ 2.34 vs 6.23+ 1.57, p=0.07) and the number of subjects with GERD diagnosed by the GerdQ (2 vs 5, Fisher's extact test, p=0.21) .
GERD is diagnosed when total acid exposure time is more than 2% or positive symptom index (SI) or positive symptom association probability ( SAP ) or endoscopy revealed LA erosive esophagitis > grade A.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Songkla
-
Hatyai, Songkla, Thailand, 90110
- NKC Institue of Gastroenterology and Hepatology, Prince of Songkla University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with one or more of the following symptoms namely epigastric pain or discomfort, postprandial fullness and early satiety with or without symptoms suggesting GERD
- Patients able to give informed consent
Exclusion Criteria:
- Patients with significant weight loss.
- Patients with hematemesis, melena ,dysphagia, intractable vomiting , palpable abdominal mass.
- Patients with history of documented peptic ulcer , gastric surgery , gastric cancer.
- Patients with symptoms compatible with irritable bowel syndrome, hepatobiliary tract disease.
- Patients with severe concomitant medical conditions, pregnant woman or continuous usage of steroids or NSIADS in the preceding 1 month before entry to the study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with GerdQ positive
Gerd Q positive was defined as score equal or more than eight.
|
Patients done GerdQ questionnaire, then undergone EGD.
The distal esophagus was examined by HD and followed by SE with a preset TE mode for esophagus ( TE-e mode ).
All patients had pH monitoring study within 1 week after the endoscopy.
|
Patients with GerdQ negative
Gerd Q neegative was defined as score less than eight.
|
Patients done GerdQ questionnaire, then undergone EGD.
The distal esophagus was examined by HD and followed by SE with a preset TE mode for esophagus ( TE-e mode ).
All patients had pH monitoring study within 1 week after the endoscopy.
|
Normal volunteers
Normal volunteers was defined as population without dyspeptic symptom.
|
Normal volunteers undergone EGD.The distal esophagus was examined by HD and followed by SE with a preset TE mode for esophagus ( TE-e mode ).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evidence of minimal change erosions detected by i-scan endoscopy.
Time Frame: within day of endoscopy
|
Minimal change lesions (MCL) included punctate erythema (PE), minute erosion (ME) and triangular lesion with elongated pit (TLE).
|
within day of endoscopy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of patients with dyspepsia are diagnosed gastroesophageal reflux disease by Gerd Q.
Time Frame: within the first 7 days after endoscopy
|
The GerdQ score equal or more than 8 is a positive score for GERD
|
within the first 7 days after endoscopy
|
Number of patients with dyspepsia are confirmed with GERD
Time Frame: within the first 7 days after endoscopy
|
GERD is diagnosed when total acid exposure time is more than 2% or positive symptom index (SI) or positive symptom association probability ( SAP ) or endoscopy revealed LA erosive esophagitis > grade A .
|
within the first 7 days after endoscopy
|
Total acid exposure in normal volunteers
Time Frame: 1 day
|
The mean value of total acid exposure of 40 normal volunteer.
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dr.Nisa Netinatsunton, MD, NKC Institue of Gastroenterology and Hepatology,Prince of Songkla University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EC 53-017-21-1-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastroesophageal Reflux Disease
-
TakedaTerminatedGastroesophageal Reflux Disease | Non-erosive Reflux DiseaseSwitzerland, Netherlands
-
Vanderbilt University Medical CenterCompletedGastroesophageal Reflux Disease (GERD) | Non-erosive Reflux Disease (NERD)United States
-
Mansoura UniversityWithdrawnGastroesophageal Reflux Disease
-
Cliniques universitaires Saint-Luc- Université...UnknownGastroesophageal Reflux DiseaseBelgium
-
GlaxoSmithKlineCompletedReflux, Gastroesophageal | Gastroesophageal Reflux DiseaseAustralia
-
King Chulalongkorn Memorial HospitalCompleted
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedGastroesophageal Reflux Disease | GERD | Acid Reflux | RefluxUnited States
-
PfizerTerminatedGastroesophageal Reflux DiseaseBrazil, Germany, Korea, Republic of, Belgium, Spain, Slovakia, France
-
GlaxoSmithKlineCompletedReflux, Gastroesophageal | Gastroesophageal Reflux DiseaseAustralia
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedGastroesophageal Reflux Disease (GERD) | RefluxUnited States, Canada
Clinical Trials on Patients with GerdQ positive
-
Maria Vittoria HospitalCompleted
-
Fondazione Italiana Linfomi ONLUSIstituto Clinico HumanitasTerminated
-
Duzce UniversityNot yet recruiting
-
Bahria UniversityCompleted
-
University Hospital, RouenUnknown
-
CNGE ConseilCompleted
-
University of La LagunaRecruiting
-
Çanakkale Onsekiz Mart UniversityCompleted
-
Zagazig UniversityCompletedBariatric Surgery CandidateEgypt